Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: a review.
about
Implantable Devices for Sustained, Intravesical Drug DeliveryAn update on the use of transdermal oxybutynin in the management of overactive bladder disorderMedical management of overactive bladderTolterodine extended release in the treatment of male OAB/storage LUTS: a systematic review.Origin of spontaneous activity in neonatal and adult rat bladders and its enhancement by stretch and muscarinic agonistsTolterodine extended-release for overactive bladder.M2 mediated contractions of human bladder from organ donors is associated with an increase in urothelial muscarinic receptors.Adaptable P-X Biaryl Phosphite/Phosphoroamidite-Containing Ligands for Asymmetric Hydrogenation and C-X Bond-Forming Reactions: Ligand Libraries with Exceptionally Wide Substrate Scope.Tolterodine for the treatment of overactive bladder: a review.Anticholinergic use in children: Persistence and patterns of therapy.Update on the management of overactive bladder: patient considerations and adherenceImpact of dose frequency on compliance and health outcomes: a literature review (1966-2006).Oxybutynin gel for the treatment of overactive bladder.Differences in Urodynamic Parameters According to the Presence of a Hunner Lesion in Women With Interstitial Cystitis/Bladder Pain Syndrome.Systematic review and meta-analysis on the efficacy and tolerability of mirabegron for the treatment of storage lower urinary tract symptoms/overactive bladder: Comparison with placebo and tolterodine.
P2860
Q26744682-0C371810-526D-42A5-91E9-6830995F2A14Q26749105-E1A824D1-0580-4FFB-9948-6CC2582A66F9Q34124065-3C870792-B780-440B-8699-2AEB2AD0D4A9Q34502903-59FD1C8C-2102-4214-8FD4-60CAD924D9B3Q34548809-1CF053F1-E25C-4F55-922D-C4B356C4E0D6Q34610640-E492E5B6-EE09-4421-8A77-2135BF36B844Q35801020-45905A4F-48E0-4942-9835-D47C85D3B85BQ36057224-CE7EEAF6-C14D-40B1-9188-E6873C692893Q36150735-B0887018-90A1-47B8-886C-7C6A153FB6E7Q36823081-585D6931-DF74-45B2-B5B2-65C1F66E9DDAQ37283704-3FF0B153-2307-4FA0-94E2-B56AE6D1CC61Q37763151-74CF17AF-B034-4E44-95F6-E03D888B7A52Q38011202-A6E4AB89-2463-4849-BB4D-E301972AF2D6Q48132162-FCD6B034-625A-4F0D-A364-9163938E2B7DQ50073415-2BA81B93-2192-4824-9899-5447FF12AA5A
P2860
Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: a review.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Once-daily, extended-release f ...... overactive bladder: a review.
@ast
Once-daily, extended-release f ...... overactive bladder: a review.
@en
Once-daily, extended-release f ...... overactive bladder: a review.
@nl
type
label
Once-daily, extended-release f ...... overactive bladder: a review.
@ast
Once-daily, extended-release f ...... overactive bladder: a review.
@en
Once-daily, extended-release f ...... overactive bladder: a review.
@nl
prefLabel
Once-daily, extended-release f ...... overactive bladder: a review.
@ast
Once-daily, extended-release f ...... overactive bladder: a review.
@en
Once-daily, extended-release f ...... overactive bladder: a review.
@nl
P1433
P1476
Once-daily, extended-release f ...... overactive bladder: a review.
@en
P2093
Eric S Rovner
P356
10.1016/S0302-2838(01)00009-4
P407
P50
P577
2002-01-01T00:00:00Z